163 related articles for article (PubMed ID: 34742483)
21. Expression of molecular markers in low-grade chondrosarcomas and cartilaginous tumors with uncertain differentiation.
Boulytcheva IV; Kushlinskii NE; Soloviev YN; Aliev MD
Klin Lab Diagn; 2013 Oct; (10):61-3, 25-30. PubMed ID: 24640098
[TBL] [Abstract][Full Text] [Related]
22. Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma.
Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
J Cancer Res Clin Oncol; 1999 Oct; 125(10):541-8. PubMed ID: 10473866
[TBL] [Abstract][Full Text] [Related]
23. New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance.
Monderer D; Luseau A; Bellec A; David E; Ponsolle S; Saiagh S; Bercegeay S; Piloquet P; Denis MG; Lodé L; Rédini F; Biger M; Heymann D; Heymann MF; Le Bot R; Gouin F; Blanchard F
Lab Invest; 2013 Oct; 93(10):1100-14. PubMed ID: 23958880
[TBL] [Abstract][Full Text] [Related]
24. Chondrosarcomas revisited.
Mavrogenis AF; Gambarotti M; Angelini A; Palmerini E; Staals EL; Ruggieri P; Papagelopoulos PJ
Orthopedics; 2012 Mar; 35(3):e379-90. PubMed ID: 22385450
[TBL] [Abstract][Full Text] [Related]
25. Morphological typing of chondrosarcoma: a study of 94 cases.
Welkerling H; Dreyer T; Delling G
Virchows Arch A Pathol Anat Histopathol; 1991; 418(5):419-25. PubMed ID: 2035255
[TBL] [Abstract][Full Text] [Related]
26. What are the differentiating clinical and MRI-features of enchondromas from low-grade chondrosarcomas?
Douis H; Parry M; Vaiyapuri S; Davies AM
Eur Radiol; 2018 Jan; 28(1):398-409. PubMed ID: 28695356
[TBL] [Abstract][Full Text] [Related]
27. From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation.
Murphey MD; Walker EA; Wilson AJ; Kransdorf MJ; Temple HT; Gannon FH
Radiographics; 2003; 23(5):1245-78. PubMed ID: 12975513
[TBL] [Abstract][Full Text] [Related]
28. Rb-loss is associated with high malignancy in chondrosarcoma.
Röpke M; Boltze C; Meyer B; Neumann HW; Roessner A; Schneider-Stock R
Oncol Rep; 2006 Jan; 15(1):89-95. PubMed ID: 16328039
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetics as a tool in the histologic subclassification of chondrosarcomas.
Dijkhuizen T; van den Berg E; Molenaar WM; Oosterhuis JW; Dam A; Wiersema J; Schraffordt Koops H; de Jong B
Cancer Genet Cytogenet; 1994 Sep; 76(2):100-5. PubMed ID: 7923056
[TBL] [Abstract][Full Text] [Related]
30. IDH-negative chondrosarcoma with metachronous dedifferentiation only in the metastatic site-A diagnostic pitfall.
Sekita T; Yoshida A; Kawai A; Ichikawa H; Kobayashi E
Genes Chromosomes Cancer; 2023 Dec; 62(12):755-760. PubMed ID: 37732625
[TBL] [Abstract][Full Text] [Related]
31. Classification of bone tumors.
Bertoni F; Bacchini P
Eur J Radiol; 1998 May; 27 Suppl 1():S74-6. PubMed ID: 9652505
[TBL] [Abstract][Full Text] [Related]
32. The role of imaging in differentiating low-grade and high-grade central chondral tumours.
Sharif B; Lindsay D; Saifuddin A
Eur J Radiol; 2021 Apr; 137():109579. PubMed ID: 33578088
[TBL] [Abstract][Full Text] [Related]
33. HEY1-NCOA2 expression modulates chondrogenic differentiation and induces mesenchymal chondrosarcoma in mice.
Tanaka M; Homme M; Teramura Y; Kumegawa K; Yamazaki Y; Yamashita K; Osato M; Maruyama R; Nakamura T
JCI Insight; 2023 May; 8(10):. PubMed ID: 37212282
[TBL] [Abstract][Full Text] [Related]
34. Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma.
Joseph NM; McGill KC; Horvai AE
Am J Surg Pathol; 2021 Jun; 45(6):812-819. PubMed ID: 33239505
[TBL] [Abstract][Full Text] [Related]
35. Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection.
Gutteridge A; Rathbone VM; Gibbons R; Bi M; Archard N; Davies KEJ; Brown J; Plagnol V; Pillay N; Amary F; O'Donnell P; Gupta M; Tirabosco R; Flanagan AM; Forshew T
Cancer Med; 2017 Oct; 6(10):2194-2202. PubMed ID: 28834325
[TBL] [Abstract][Full Text] [Related]
36. Chondrosarcoma: biology, genetics, and epigenetics.
Chow WA
F1000Res; 2018; 7():. PubMed ID: 30519452
[TBL] [Abstract][Full Text] [Related]
37. Chondroblastoma and clear cell chondrosarcoma: radiological and MRI characteristics with histopathological correlation.
Kaim AH; Hügli R; Bonél HM; Jundt G
Skeletal Radiol; 2002 Feb; 31(2):88-95. PubMed ID: 11828329
[TBL] [Abstract][Full Text] [Related]
38. The clinical approach towards chondrosarcoma.
Gelderblom H; Hogendoorn PC; Dijkstra SD; van Rijswijk CS; Krol AD; Taminiau AH; Bovée JV
Oncologist; 2008 Mar; 13(3):320-9. PubMed ID: 18378543
[TBL] [Abstract][Full Text] [Related]
39. Enneking type III resection of pubic chondrosarcoma: A case report.
Zaizi A; Badaoui R; Rabah A; Aboulfateh M; Khmamouch MR; Bouabid AS; Boussouga M
Ann Med Surg (Lond); 2022 Feb; 74():103270. PubMed ID: 35145661
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
